Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Return Level : 87.11 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 87.11 |
| August 20, 2026 | 87.47 |
| August 19, 2026 | 89.41 |
| August 18, 2026 | 87.90 |
| August 17, 2026 | 88.70 |
| August 14, 2026 | 86.64 |
| August 13, 2026 | 85.59 |
| August 12, 2026 | 87.25 |
| August 11, 2026 | 89.24 |
| August 10, 2026 | 88.33 |
| August 07, 2026 | 87.65 |
| August 06, 2026 | 85.83 |
| August 05, 2026 | 86.91 |
| August 04, 2026 | 89.59 |
| August 03, 2026 | 86.01 |
| July 31, 2026 | 84.65 |
| July 30, 2026 | 87.32 |
| July 29, 2026 | 86.22 |
| July 28, 2026 | 85.78 |
| July 27, 2026 | 85.53 |
| July 24, 2026 | 85.60 |
| July 23, 2026 | 86.78 |
| July 22, 2026 | 88.70 |
| July 21, 2026 | 74.52 |
| July 20, 2026 | 71.65 |
| Date | Value |
|---|---|
| July 17, 2026 | 74.30 |
| July 16, 2026 | 71.38 |
| July 15, 2026 | 71.82 |
| July 14, 2026 | 71.91 |
| July 13, 2026 | 74.11 |
| July 10, 2026 | 76.40 |
| July 09, 2026 | 84.00 |
| July 08, 2026 | 85.74 |
| July 07, 2026 | 86.97 |
| July 06, 2026 | 86.55 |
| July 02, 2026 | 83.99 |
| July 01, 2026 | 80.44 |
| June 30, 2026 | 81.51 |
| June 29, 2026 | 80.50 |
| June 26, 2026 | 78.89 |
| June 25, 2026 | 79.27 |
| June 24, 2026 | 79.81 |
| June 23, 2026 | 79.90 |
| June 22, 2026 | 82.00 |
| June 18, 2026 | 81.82 |
| June 17, 2026 | 81.04 |
| June 16, 2026 | 76.55 |
| June 15, 2026 | 77.15 |
| June 12, 2026 | 74.52 |
| June 11, 2026 | 74.41 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Sarepta Therapeutics, Inc. | 18.79 |
| Intellia Therapeutics, Inc. | 12.84 |
| Denali Therapeutics, Inc. | 24.92 |
| Twist Bioscience Corp. | 145.59 |
| Revolution Medicines, Inc. | 209.46 |